Cargando…

Molecular Insights into the Classification of Luminal Breast Cancers: The Genomic Heterogeneity of Progesterone-Negative Tumors

Estrogen receptor (ER)-positive progesterone receptor (PR)-negative breast cancers are infrequent but clinically challenging. Despite the volume of genomic data available on these tumors, their biology remains poorly understood. Here, we aimed to identify clinically relevant subclasses of ER+/PR− br...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lopez, Gianluca, Costanza, Jole, Colleoni, Matteo, Fontana, Laura, Ferrero, Stefano, Miozzo, Monica, Fusco, Nicola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6386970/ https://www.ncbi.nlm.nih.gov/pubmed/30691046 http://dx.doi.org/10.3390/ijms20030510

Ejemplares similares

The Genetic Landscape of Human Glioblastoma and Matched Primary Cancer Stem Cells Reveals Intratumour Similarity and Intertumour Heterogeneity
por: Pesenti, Chiara, et al.
Publicado: (2019)

Analysis of BRCA1 and RAD51C Promoter Methylation in Italian Families at High-Risk of Breast and Ovarian Cancer
por: Tabano, Silvia, et al.
Publicado: (2020)

Difference between Luminal A and Luminal B Subtypes According to Ki-67, Tumor Size, and Progesterone Receptor Negativity Providing Prognostic Information
por: Inic, Zorka, et al.
Publicado: (2014)

Prognostic values of negative estrogen or progesterone receptor expression in patients with luminal B HER2-negative breast cancer
por: Park, Chansub, et al.
Publicado: (2016)

PROGNOSTIC IMPACT OF LOW ESTROGEN AND PROGESTERONE POSITIVITY IN LUMINAL B (HER2 NEGATIVE) BREAST CANCER
por: Rajc, Jasmina, et al.
Publicado: (2018)

Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes
por: Maisonneuve, Patrick, et al.
Publicado: (2014)

Negative progesterone receptor status correlates with increased risk of breast cancer recurrence in luminal B HER2-positive and -negative subtypes
por: Utsumi, Toshiaki, et al.
Publicado: (2021)

3300 Progesterone receptor alters lipid biology in luminal breast cancer
por: Ward, Ashley Vanessa, et al.
Publicado: (2019)

(Epi)genetic profiling of extraembryonic and postnatal tissues from female monozygotic twins discordant for Beckwith–Wiedemann syndrome
por: Fontana, Laura, et al.
Publicado: (2020)

PTEN Expression as a Complementary Biomarker for Mismatch Repair Testing in Breast Cancer
por: Lopez, Gianluca, et al.
Publicado: (2020)

A novel de novo DDX3X missense variant in a female with brachycephaly and intellectual disability: a case report
por: Moresco, Giada, et al.
Publicado: (2021)

Molecular heterogeneity of luminal breast cancer
por: Loi, S
Publicado: (2011)

Optimal management of luminal breast cancer: how much endocrine therapy is long enough?
por: Munzone, Elisabetta, et al.
Publicado: (2018)

Modeling luminal breast cancer heterogeneity: combination therapy to suppress a hormone receptor-negative, cytokeratin 5-positive subpopulation in luminal disease
por: Knox, Aaron J, et al.
Publicado: (2014)

SF3B1 mutation is a poor prognostic indicator in luminal B and progesterone receptor-negative breast cancer patients
por: Fu, Xing, et al.
Publicado: (2017)

Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis
por: Diana, Anna, et al.
Publicado: (2022)

Global signalling network analysis of luminal T47D breast cancer cells in response to progesterone
por: Wright, Roni H. G., et al.
Publicado: (2022)

Mismatch Repair Protein Loss as a Prognostic and Predictive Biomarker in Breast Cancers Regardless of Microsatellite Instability
por: Fusco, Nicola, et al.
Publicado: (2018)

FGF7/FGFR2–JunB signalling counteracts the effect of progesterone in luminal breast cancer
por: Mieczkowski, Kamil, et al.
Publicado: (2022)

Molecular and Immunohistochemical Markers with Prognostic and Predictive Significance in Liver Metastases from Colorectal Carcinoma
por: Lopez, Gianluca, et al.
Publicado: (2018)

A HS6ST2 gene variant associated with X‐linked intellectual disability and severe myopia in two male twins
por: Paganini, Leda, et al.
Publicado: (2018)

Junctional Adhesion Molecule 2 Mediates the Interaction between Hatched Blastocyst and Luminal Epithelium: Induction by Progesterone and LIF
por: Su, Ren-Wei, et al.
Publicado: (2012)

Progesterone Receptor Status and Ki-67 Index May Predict Early Relapse in Luminal B/HER2 Negative Breast Cancer Patients: A Retrospective Study
por: Zong, Yu, et al.
Publicado: (2014)

Novel Pathogenetic Variants in PTHLH and TRPS1 Genes Causing Syndromic Brachydactyly
por: Elli, Francesca Marta, et al.
Publicado: (2022)

Extensive Placental Methylation Profiling in Normal Pregnancies
por: Rondinone, Ornella, et al.
Publicado: (2021)

Correction: Rondinone et al. Extensive Placental Methylation Profiling in Normal Pregnancies. Int. J. Mol. Sci. 2021, 22, 2136
por: Rondinone, Ornella, et al.
Publicado: (2022)

A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
por: Prado-Vázquez, Guillermo, et al.
Publicado: (2019)

Luminal breast cancer metastases and tumor arousal from dormancy are promoted by direct actions of estradiol and progesterone on the malignant cells
por: Ogba, Ndiya, et al.
Publicado: (2014)

Association of Menopausal Status, Expression of Progesterone Receptor and Ki67 to the Clinical Response to Neoadjuvant Chemotherapy in Luminal Breast Cancer
por: Silva, Leonardo Roberto da, et al.
Publicado: (2019)

Classification of Cerebral Lymphomas and Glioblastomas Featuring Luminance Distribution Analysis
por: Yamasaki, Toshihiko, et al.
Publicado: (2013)

Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers
por: Sung, Hyuna, et al.
Publicado: (2016)

Multipotent luminal mammary cancer stem cells model tumor heterogeneity
por: Bao, Lei, et al.
Publicado: (2015)

Immune gene expression profiling reveals heterogeneity in luminal breast tumors
por: Zhu, Bin, et al.
Publicado: (2019)

The Genetic and Epigenetic Footprint in Idiopathic Pulmonary Fibrosis and Familial Pulmonary Fibrosis: A State-of-the-Art Review
por: Tirelli, Claudio, et al.
Publicado: (2022)

THE TOTAL LUMINOUS EFFICIENCY OF LUMINOUS BACTERIA
por: Harvey, E. Newton
Publicado: (1925)

Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
por: Patten, Darren K., et al.
Publicado: (2018)

Intratumoral Heterogeneity of Expression of 16 miRNA in Luminal Cancer of the Mammary Gland
por: Veryaskina, Yuliya A., et al.
Publicado: (2020)

Progesterone receptor isoforms A and B: new insights into the mechanism of progesterone resistance for the treatment of endometrial carcinoma
por: Shao, Ruijin
Publicado: (2013)

Progesterone effects on the oligodendrocyte linage: all roads lead to the progesterone receptor
por: Jure, Ignacio, et al.
Publicado: (2019)

Progesterone metabolites regulate induction, growth, and suppression of estrogen- and progesterone receptor-negative human breast cell tumors
por: Wiebe, John P, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e5d0lhp45c6fk66da8r62pn7p1